Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor Deficiency
暂无分享,去创建一个
[1] Jay L. Martello,et al. Ecallantide for treatment of acute attacks of hereditary angioedema. , 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[2] M. Triggiani,et al. Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group , 2012, Allergy.
[3] P. Busse,et al. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial. , 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[4] B. Chipps. Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema , 2011, Pediatrics.
[5] W. Lumry,et al. Safety and Efficacy of Nanofiltered C1 Esterase Inhibitor (Human) (Cinryze™) for the Treatment of Laryngeal Attacks in Subjects with Hereditary Angioedema (HAE) , 2011 .
[6] W. Lumry,et al. Pre-procedure Administration of C1 Esterase Inhibitor (Human) (Cinryze™) for the Prevention of Hereditary Angioedema (HAE) Attacks after Medical, Dental, or Surgical Procedures , 2011 .
[7] W. Lumry,et al. Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies , 2011, The World Allergy Organization journal.
[8] J. Nuijens,et al. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. , 2010, The Journal of allergy and clinical immunology.
[9] William H. Yang,et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. , 2010, The New England journal of medicine.
[10] A. Kaplan,et al. The plasma bradykinin-forming pathways and its interrelationships with complement. , 2010, Molecular immunology.
[11] T. Bowen. Hereditary Angioedema Consensus 2010 , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.
[12] H. Farkas. Management of upper airway edema caused by hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.
[13] P. Keith,et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.
[14] M. Gompels,et al. HAE international home therapy consensus document , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.
[15] K. Bork. Recurrent angioedema and the threat of asphyxiation. , 2010, Deutsches Arzteblatt international.
[16] T. Craig,et al. Summary of the International Multicenter Prospective Angioedema C1-inhibitor Trials 1 and 2 (IMPACT1 and 2) , 2010, Expert review of clinical immunology.
[17] M. Smythe,et al. Unfractionated Heparin Dosing for Venous Thromboembolism in Morbidly Obese Patients: Case Report and Review of the Literature , 2010, Pharmacotherapy.
[18] J. Bernstein,et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. , 2009, The Journal of allergy and clinical immunology.
[19] T. Craig,et al. When is prophylaxis for hereditary angioedema necessary? , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[20] M. Cicardi,et al. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. , 2009, Trends in molecular medicine.
[21] H. Farkas,et al. Disease expression in women with hereditary angioedema. , 2008, American journal of obstetrics and gynecology.
[22] K. Bork,et al. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[23] G. Kojda,et al. Nonallergic angioedema: role of bradykinin , 2007, Allergy.
[24] M. Frank. Hereditary angioedema: the clinical syndrome and its management in the United States. , 2006, Immunology and allergy clinics of North America.
[25] L. Romics,et al. Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. , 2005, The Journal of allergy and clinical immunology.
[26] M. Gompels,et al. C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.
[27] A. Tordai,et al. HAEdb: A novel interactive, locus‐specific mutation database for the C1 inhibitor gene , 2005, Human mutation.
[28] A. Tordai,et al. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.
[29] W. Tremaine,et al. Hereditary angioedema: a broad review for clinicians. , 2001, Archives of internal medicine.
[30] H. Farkas,et al. Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema , 2001, European journal of gastroenterology & hepatology.
[31] H. Farkas,et al. The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures. , 1999, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[32] K. Bork,et al. Hepatocellular adenomas in patients taking danazol for here ditary angiooedema , 1999, The Lancet.
[33] M. Tosi. Molecular genetics of C1 inhibitor. , 1998, Immunobiology.
[34] M. Cicardi,et al. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. , 1997, The Journal of allergy and clinical immunology.
[35] M. Cicardi,et al. Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.
[36] F. Rosen,et al. Hereditary Angioneurotic Edema: Two Genetic Variants , 1965, Science.
[37] R. R. Evans,et al. A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.